Aardvark Therapeutics, Inc.
AARD
$5.39
$0.020.37%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -179.73% | -252.14% | -211.10% | -252.81% | -185.63% |
| Total Depreciation and Amortization | 125.00% | 153.13% | 169.57% | 190.48% | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 231.91% | 90.80% | -34.60% | -44.10% | -37.75% |
| Change in Net Operating Assets | -77.37% | 27.00% | 122.97% | -172.73% | 2,041.98% |
| Cash from Operations | -199.51% | -291.53% | -259.87% | -321.55% | -210.56% |
| Capital Expenditure | 12.84% | 1.94% | -4.08% | -1,980.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -316.96% | -- | -- | -- | -- |
| Cash from Investing | -313.96% | -83,263.11% | -117,364.29% | -2,492,240.00% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 27,501.20% | 54,056.80% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -100.00% | -100.00% | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 28.55% | -64.70% | -78.19% | -- | -- |
| Cash from Financing | 8.85% | 5.97% | 5.92% | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -128.11% | -160.22% | -181.65% | 392.77% | 991.24% |